DrugPatentWatch Database Preview
Ingenus Pharms Llc Company Profile
Email this page to a colleague
» See Plans and PricingWhat is the competitive landscape for INGENUS PHARMS LLC, and what generic and branded alternatives to INGENUS PHARMS LLC drugs are available?
INGENUS PHARMS LLC has seventeen approved drugs.
Summary for Ingenus Pharms Llc
| US Patents: | 0 |
| Tradenames: | 16 |
| Ingredients: | 16 |
| NDAs: | 17 |
Drugs and US Patents for Ingenus Pharms Llc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ingenus Pharms Llc | GEMCITABINE HYDROCHLORIDE | gemcitabine hydrochloride | INJECTABLE;INJECTION | 210383-003 | Feb 14, 2019 | DISCN | No | No | Start Trial | Start Trial | |||||
| Ingenus Pharms Llc | GEMCITABINE HYDROCHLORIDE | gemcitabine hydrochloride | INJECTABLE;INJECTION | 210383-001 | Feb 14, 2019 | DISCN | No | No | Start Trial | Start Trial | |||||
| Ingenus Pharms Llc | CARBOPLATIN | carboplatin | INJECTABLE;INTRAVENOUS | 208487-004 | Apr 26, 2017 | AP | RX | No | No | Start Trial | Start Trial | ||||
| Ingenus Pharms Llc | CARBOPLATIN | carboplatin | INJECTABLE;INTRAVENOUS | 208487-001 | Apr 26, 2017 | AP | RX | No | No | Start Trial | Start Trial | ||||
| Ingenus Pharms Llc | DOCETAXEL | docetaxel | INJECTABLE;INJECTION | 207563-002 | Aug 31, 2017 | AP | RX | No | No | Start Trial | Start Trial | ||||
| Ingenus Pharms Llc | CARBOPLATIN | carboplatin | INJECTABLE;INTRAVENOUS | 208487-003 | Apr 26, 2017 | AP | RX | No | No | Start Trial | Start Trial | ||||
| Ingenus Pharms Llc | IRINOTECAN HYDROCHLORIDE | irinotecan hydrochloride | INJECTABLE;INJECTION | 206935-001 | May 26, 2017 | AP | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
